Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.

NPJ Digit Med · 2024 · PMC11375004 · PMID 39232033

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The interim results showed a trend of deteriorating function across the AD spectrum (preclinical to mild AD) across various features of several RMTs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.